Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 212007
Company: EXELA PHARMA

Products on ANDA 212007

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ZINC CHLORIDE	ZINC CHLORIDE	EQ 1MG ZINC/ML	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 212007

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/21/2021	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/212007Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 212007

ZINC CHLORIDE

INJECTABLE;INJECTION; EQ 1MG ZINC/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ZINC CHLORIDE	ZINC CHLORIDE	EQ 1MG ZINC/ML	INJECTABLE;INJECTION	Prescription	No	AP	212007	EXELA PHARMA
ZINC CHLORIDE IN PLASTIC CONTAINER	ZINC CHLORIDE	EQ 1MG ZINC/ML	INJECTABLE;INJECTION	Prescription	Yes	AP	018959	HOSPIRA